Premium
S2‐03‐04: Reverse chemical genetics approach to identify druggable gene products in Alzheimer's disease
Author(s) -
Kim Tae-Wan
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.288
Subject(s) - amyloid precursor protein , small molecule , ectodomain , proteases , alpha secretase , amyloid precursor protein secretase , druggability , amyloid beta , cleavage (geology) , drug discovery , chemistry , senile plaques , high throughput screening , chemical biology , alzheimer's disease , phenotypic screening , microbiology and biotechnology , biochemistry , biology , peptide , gene , phenotype , enzyme , disease , medicine , paleontology , receptor , pathology , fracture (geology)